Sanofi-aventis and the Massachusetts Institute of Technology (MIT) Center for Biomedical Innovation have struck a strategic alliance to advance cutting-edge research and foster collaboration between academia and industry.

The Sanofi-aventis Biomedical Innovation Program (SABIP) will encourage basic and applied research and promote scientific exchange between MIT and Sanofi-aventis.

The alliance will give Sanofi-aventis the opportunity to develop any therapeutic, diagnostic and prognostic applications based on the discoveries made during the alliance.

The SABIP will support a number of activities over the next three years via Biomedical Innovation Funding Awards, which will provide MIT researchers with the support to develop innovative research projects.